The disclosure provides Apo-2 ligand variant polypeptides. Methods of making and chemically modifying Apo-2 ligand variant polypeptides are also provided. In addition, formulations of Apo-2 ligand variant polypeptides are provided. In addition, therapeutic methods for using Apo-2 ligand variant polypeptides are provided.
申请公布号
WO2004001009(A2)
申请公布日期
2003.12.31
申请号
WO2003US19750
申请日期
2003.06.23
申请人
GENENTECH, INC.;HYMOWITZ, SARAH;KELLEY, ROBERT, F.;LINDSTROM, STEPHANIE, HO
发明人
HYMOWITZ, SARAH;KELLEY, ROBERT, F.;LINDSTROM, STEPHANIE, HO